Clinical Trial Update: Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating standing Advair prescriptions with a written action plan for managing COPD exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: COPD, Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED